UBS (Lux) Equity Fund - Biotech Q Fonds
89,68
EUR
-1,60
EUR
-1,75
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Vertex Pharmaceuticals Inc | US92532F1003 | 9,59% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 7,07% |
| Neurocrine Biosciences Inc | US64125C1099 | 5,04% |
| Guardant Health Inc | US40131M1099 | 4,67% |
| Gilead Sciences Inc | US3755581036 | 4,61% |
| AbbVie Inc | US00287Y1091 | 4,37% |
| Sandoz Group AG Registered Shares | CH1243598427 | 3,91% |
| Amgen Inc | US0311621009 | 3,90% |
| Royalty Pharma PLC Class A | GB00BMVP7Y09 | 3,49% |
| Roivant Sciences Ltd Ordinary Shares | BMG762791017 | 3,33% |
| Sonstige | 50,02% |